Alto Neuroscience ANRO Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
Based on the most recent quarter.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's cash ratio?
- Alto Neuroscience (ANRO) reported cash ratio of 20.1× in Q1 2026.
- How has Alto Neuroscience's cash ratio changed year-over-year?
- Alto Neuroscience's cash ratio decreased by 9.3% year-over-year, from 22.2× to 20.1×.
- What is the long-term trend for Alto Neuroscience's cash ratio?
- Over 2 years (2023 to 2025), Alto Neuroscience's cash ratio has grown at a 3.1% compound annual growth rate (CAGR), from 14.7× to 15.6×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.